EFFECTS OF CHANGES IN CONDITIONING REGIMEN AND SUPPORTIVE CARE ON OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT)

被引：0
|
作者：
Abello, V [1 ]
Rosales, C. [1 ]
Pedraza, E. [1 ]
Linares, A. [1 ]
Esguerra, H. [1 ]
Rosales, M. [1 ]
Figueroa, J. [1 ]
机构：
[1] Clin Marly, Bogota, Colombia
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
200
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [31] Allogeneic stem cell transplantation (Allo-SCT) for Acute Lymphoblastic Leukemia (ALL) in adult patients - are we doing better?
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S103 - S104
  • [32] Outcomes of Allogeneic Stem Cell Transplant (Allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) in Patients Older Than 75 Years: A Single Center Analysis
    Nath, Rajneesh
    Cerny, Jan
    Ramanathan, Muthalagu
    Zhou, Zheng
    Yu, Neng
    Raffel, Glen D.
    Bednarik, Jayde
    BLOOD, 2016, 128 (22)
  • [33] IMPACT OF CYTOGENETICS RISK ON OUTCOME AFTER REDUCED INTENSITY CONDITIONING (RIC) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FROM AN HLA IDENTICAL SIBLING FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CRI)
    Mobty, M.
    Labopin, M.
    Milpied, N.
    Cornelissen, J. J.
    Blaise, D.
    Petersen, E.
    Theorin, N.
    Goker, H.
    Socie, G.
    Rocha, V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 21 - 21
  • [34] Long-Term Immune Deficiency (ID) after Allogeneic Stem Cell Transplantation (allo-SCT) Following a Myeloablative (MA) Conditioning Regimen
    Corre, Elise
    Cannagnat, Maryvonnick
    Busson, Marc
    de Latour, Regis Peffault
    Robin, Marie
    Ribaud, Patricia
    Toubert, Antoine
    Rabian, Claire
    Socie, Gerard
    BLOOD, 2008, 112 (11) : 742 - 743
  • [35] Fertility in Female Patients After Allogeneic Stem Cell Transplantation Following Reduced-Intensity Conditioning (RIC allo-SCT)
    Assouline, Emmanuelle
    Crocchiolo, Roberto
    Prebet, Thomas
    Furst, Sabine
    El-Cheikh, Jean
    Florence, Broussais
    Coso, Diane
    Charbonnier, Aude
    Chabannon, Christian
    Vey, Norbert
    Marc, Gamerre
    Blaise, Didier
    Courbiere, Blandine
    BLOOD, 2011, 118 (21) : 1318 - 1318
  • [36] Extramedullary Relapses after Allogeneic Stem Cell Transplant (allo-SCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL)
    Shimizu, Hiroaki
    Ishizaki, Takuma
    Hatsumi, Nahoko
    Takada, Satoru
    Yokohama, Akihiko
    Saitoh, Takayuki
    Sakura, Toru
    Handa, Hiroshi
    BLOOD, 2019, 134
  • [37] Clofarabine Containing Conditioning Regimen for Allo-SCT in AML/ALL Patients: A Survey From the Acute Leukemia Working Party of EBMT
    Chevallier, Patrice
    Labopin, Myriam
    Buchholz, Stefanie
    Ganser, Arnold
    Ciceri, Fabio
    Lioure, Bruno
    Faul, Christoph
    Guillerm, Gaelle
    Finke, Juergen
    Huynh, Anne
    Schubert, Joerg
    Kolb, Hans Jochem
    Polge, Emmanuelle
    Nagler, Arnon
    Mohty, Mohamad
    BLOOD, 2011, 118 (21) : 1294 - 1294
  • [38] What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?
    Steffen T. Simon
    Anne Pralong
    Michael Hallek
    Christoph Scheid
    Udo Holtick
    Marco Herling
    Annals of Hematology, 2021, 100 : 1377 - 1389
  • [39] Salvage Therapy with Hypomethylating Agents (HMA) and/or Lenalidomide (len) for Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Relapse Following Allogeneic Stem Cell Transplantation (allo-SCT)
    Singh, Meenu
    Dhakal, Binod
    Shrestha, Anuj
    Atallah, Ehab
    Carlson, Karen
    Pasquini, Marcelo C.
    Rein, Lisa
    Banerjee, Anjishnu
    Esselmann, Jean
    Ramirez, Sarah
    Zellner, Katie
    Essenmacher, Amber
    Hari, Parameswaran N.
    Michaelis, Laura C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S357 - S357
  • [40] What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?
    Simon, Steffen T.
    Pralong, Anne
    Hallek, Michael
    Scheid, Christoph
    Holtick, Udo
    Herling, Marco
    ANNALS OF HEMATOLOGY, 2021, 100 (06) : 1377 - 1389
12345